Zuo J - Search Results

1

Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.

Yu X, Wang M, Zuo J, Wahafu A, Mao P, Li R, Wu W, Xie W, Wang J. Yu X, et al. Among authors: zuo j. Life Sci. 2019 Nov 1;236:116917. doi: 10.1016/j.lfs.2019.116917. Epub 2019 Oct 12. Life Sci. 2019. PMID: 31614149 Free article.

2

Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.

Wang J, Zuo J, Wang M, Ma X, Gao K, Bai X, Wang N, Xie W, Liu H. Wang J, et al. Among authors: zuo j. Oncol Rep. 2019 Apr;41(4):2159-2167. doi: 10.3892/or.2019.7012. Epub 2019 Feb 14. Oncol Rep. 2019. PMID: 30816483 Free PMC article.

3

Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.

Wang J, Zuo J, Wahafu A, Wang MD, Li RC, Xie WF. Wang J, et al. Among authors: zuo j. CNS Neurosci Ther. 2020 Mar;26(3):297-308. doi: 10.1111/cns.13197. Epub 2019 Jul 18. CNS Neurosci Ther. 2020. PMID: 31318172 Free PMC article.

4

Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.

Alafate W, Zuo J, Deng Z, Guo X, Wu W, Zhang W, Xie W, Wang M, Wang J. Alafate W, et al. Among authors: zuo j. Pathol Res Pract. 2019 Oct;215(10):152557. doi: 10.1016/j.prp.2019.152557. Epub 2019 Jul 23. Pathol Res Pract. 2019. PMID: 31353228

5

Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.

Alafate W, Wang M, Zuo J, Wu W, Sun L, Liu C, Xie W, Wang J. Alafate W, et al. Among authors: zuo j. Pathol Res Pract. 2019 Nov;215(11):152617. doi: 10.1016/j.prp.2019.152617. Epub 2019 Aug 23. Pathol Res Pract. 2019. PMID: 31563286

6

Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.

Alafate W, Li X, Zuo J, Zhang H, Xiang J, Wu W, Xie W, Bai X, Wang M, Wang J. Alafate W, et al. Among authors: zuo j. CNS Neurosci Ther. 2020 Apr;26(4):475-485. doi: 10.1111/cns.13297. CNS Neurosci Ther. 2020. PMID: 32187449 Free PMC article.

7

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma.

Wang J, Zuo J, Wang MD, Xie WF, Bai XB, Ma XD. Wang J, et al. Among authors: zuo j. CNS Neurosci Ther. 2020 Jul;26(7):777. doi: 10.1111/cns.13227. Epub 2019 Oct 2. CNS Neurosci Ther. 2020. PMID: 31578804 Free PMC article. Retracted.

8

WITHDRAWN: ESM1-dependent mesenchymal transition enhances radioresistance of glioblastoma via transcriptional regulation of NFκB.

Wang J, Zuo J, Wahafu A, Yu H, Xie W, Zhang H, Wang M. Wang J, et al. Among authors: zuo j. Biochem Biophys Res Commun. 2019 Oct 24:S0006-291X(19)32028-5. doi: 10.1016/j.bbrc.2019.10.126. Online ahead of print. Biochem Biophys Res Commun. 2019. PMID: 31668814

9

GPIHBP1 increase accounts for rheumatic arthritis-related hypotriglyceridemia by facilitating lipids uptake of white adipose tissues.

Song MK, Gu MF, Liu L, He LJ, Ye P, Yang K, Wang DD, Olatunji OJ, Yin Q, Zuo J. Song MK, et al. Among authors: zuo j. Arthritis Res Ther. 2025 Jan 25;27(1):16. doi: 10.1186/s13075-025-03483-1. Arthritis Res Ther. 2025. PMID: 39856718 Free article.

10

Characteristics and environmental significance of sulfur isotope signatures in the water environment of typical pyrite mines.

Zhou W, Liu P, Zhou J, Liu J, Wang C, Mu H, Jia H, Zuo J. Zhou W, et al. Among authors: zuo j. J Environ Sci (China). 2025 Jul;153:10-21. doi: 10.1016/j.jes.2023.12.012. Epub 2024 Jan 5. J Environ Sci (China). 2025. PMID: 39855783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,855 results

Search Page

Filters